Joseph E Payne insider trades

Open-market stock purchases and sales by Joseph E Payne, President and CEO at Arcturus Therapeutics Holdings Inc, from SEC Form 4 filings since Feb 7, 2019.

Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -56%.

Recent trades

DateStockTradeValue
Dec 17, 2025ARCT Arcturus Therapeutics Holdings IncBought (not open market)—

Companies traded

  • ARCT Arcturus Therapeutics Holdings Inc: 3 buys, last Dec 17, 2025
  • VLON Vallon Pharmaceuticals, Inc: 2 buys, last Jun 9, 2022

Get free alerts when Joseph E Payne files a new trade →